サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541049

血液製剤市場レポート：製品別、抗血栓・抗凝固剤タイプ別、抗血栓・抗凝固剤用途別、地域別、2024～2032年

Blood Preparation Market Report by Product, Antithrombotic and Anticoagulants Type, Antithrombotic and Anticoagulants Application, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 141 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血液製剤市場レポート：製品別、抗血栓・抗凝固剤タイプ別、抗血栓・抗凝固剤用途別、地域別、2024～2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 141 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の血液製剤市場規模は2023年に444億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに649億米ドルに達し、2024～2032年の間に4.2％の成長率（CAGR）を示すと予測しています。

献血は、ドナーから1単位の血液を採取する救命処置です。この血液は細胞要素、コロイド、結晶質の混合物から成り、患者に使用するためにはこれらを分離する必要があります。その結果、血液製剤は、冷蔵遠心分離機を用いて1単位の全血を異なる成分に分離する方法が広く採用されています。これらの成分には一般に、凍結沈殿物、血小板濃縮物、新鮮凍結血漿、充填赤血球（PRBC）濃縮物が含まれます。血液製剤はまた、各血液成分の異なる用途に対する有用性を最大限に引き出すものです。

血液製剤市場傾向：

コロナウイルス感染症（COVID-19）の患者が急増し、効果的な治療法がないため、いくつかの病院では重篤な状態の患者に対する有望な治療法として回復期血漿に頼っています。これは、健康な献血から血漿を分離する血液製剤の必要性にプラスの影響を与えている重要な要因の一つです。これとは別に、貧血、鎌状赤血球症、血友病、がんなどの慢性疾患の有病率の増加が輸血需要を刺激しています。これは、世界中の政府や非政府組織（NGO）が実施する啓発キャンペーンによる献血者数の増加と相まって、市場の成長に寄与しています。これに伴い、外科手術件数の大幅な増加も市場の成長を後押ししています。さらに、複数の医療機関が血液成分の迅速な分離のために高度なデジタル技術の採用に注力しています。また、血液の在庫記録を管理するために無線自動識別（RFID）技術を活用しており、今後数年間で血液製剤の用途が拡大すると予想されます。

本レポートで扱う主要質問

  • 2023年の世界の血液製剤市場の市場規模は？
  • 2024～2032年の世界の血液製剤市場の予想成長率は？
  • 世界の血液製剤市場を牽引する主要因は何か？
  • 世界の血液製剤市場に対するCOVID-19の影響は？
  • 世界の血液製剤市場の製品別内訳は？
  • 世界の血液製剤市場の抗血栓・抗凝固剤タイプ別内訳は？
  • 世界の血液製剤市場の抗血栓・抗凝固剤用途別内訳は？
  • 世界の血液製剤市場における主要地域は？
  • 世界の血液製剤市場における主要参入企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の血液製剤市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 全血
    • 市場動向
    • 主要セグメント
      • 赤血球
      • 顆粒球
      • プラズマ
      • 血小板
    • 市場予測
  • 血液成分
    • 市場動向
    • 主要セグメント
      • 全血成分
      • 赤血球濃縮液
      • 白血球減少赤血球
      • 凍結血漿
      • 血小板濃縮液
      • クリオプレシピテート
    • 市場予測
  • 血液製剤

第7章 市場内訳：抗血栓・抗凝固剤タイプ別

  • 血小板凝集抑制剤
    • 市場動向
    • 主要セグメント
      • 糖タンパク質阻害剤
      • COX阻害剤
      • ADP拮抗薬
      • その他
    • 市場予測
  • 線維素溶解薬
    • 市場動向
    • 主要セグメント
      • 組織プラスミノーゲン活性化因子（TPA）
      • ストレプトキナーゼ
      • ウロキナーゼ
    • 市場予測
  • 抗凝固剤
    • 市場動向
    • 主要セグメント
      • ヘパリン
      • ビタミンK拮抗薬
      • 直接トロンビン阻害剤
      • 直接因子Xa阻害剤
    • 市場予測

第8章 市場内訳：抗血栓・抗凝固剤用途別

  • 血小板増多症
  • 肺塞栓症
  • 腎機能障害
  • 狭心症の血管合併症
  • その他

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Baxter International Inc.
    • Boehringer Ingelheim International GmbH
    • Bristol-Myers Squibb Company
    • Daiichi Sankyo Company Limited
    • GlaxoSmithKline PLC
    • Johnson & Johnson Services Inc.
    • LEO Pharma A/S
    • Pfizer Inc.
    • Portola Pharmaceuticals Inc.（Alexion Pharmaceuticals Inc.）
    • Sanofi S.A.
図表

List of Figures

  • Figure 1: Global: Blood Preparation Market: Major Drivers and Challenges
  • Figure 2: Global: Blood Preparation Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Blood Preparation Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Blood Preparation Market: Breakup by Product (in %), 2023
  • Figure 5: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Type (in %), 2023
  • Figure 6: Global: Blood Preparation Market: Breakup by Antithrombotic and Anticoagulants Application (in %), 2023
  • Figure 7: Global: Blood Preparation Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Blood Preparation (Whole Blood) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Blood Preparation (Whole Blood) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Blood Preparation (Blood Components) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Blood Preparation (Blood Components) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Blood Preparation (Blood Derivatives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Blood Preparation (Blood Derivatives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Blood Preparation (Platelet Aggregation Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Blood Preparation (Fibrinolytics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Blood Preparation (Fibrinolytics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Blood Preparation (Anticoagulants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Blood Preparation (Anticoagulants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Blood Preparation (Thrombocytosis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Blood Preparation (Thrombocytosis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Blood Preparation (Pulmonary Embolism) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Blood Preparation (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Blood Preparation (Renal Impairment) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Blood Preparation (Renal Impairment) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Blood Preparation (Angina Blood Vessel Complications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Blood Preparation (Angina Blood Vessel Complications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Blood Preparation (Other Antithrombotic and Anticoagulant Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: North America: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: North America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: United States: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: United States: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Canada: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Canada: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Asia-Pacific: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Asia-Pacific: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: China: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: China: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Japan: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Japan: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: India: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: India: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: South Korea: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: South Korea: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Australia: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Australia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Indonesia: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Indonesia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Others: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Europe: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Europe: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Germany: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Germany: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: France: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: France: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: United Kingdom: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: United Kingdom: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Italy: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Italy: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Spain: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Spain: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Russia: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Russia: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Latin America: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Latin America: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Brazil: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Brazil: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Mexico: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Mexico: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Middle East and Africa: Blood Preparation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Middle East and Africa: Blood Preparation Market: Breakup by Country (in %), 2023
  • Figure 78: Middle East and Africa: Blood Preparation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Global: Blood Preparation Industry: SWOT Analysis
  • Figure 80: Global: Blood Preparation Industry: Value Chain Analysis
  • Figure 81: Global: Blood Preparation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Blood Preparation Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Blood Preparation Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 3: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Type (in Million US$), 2024-2032
  • Table 4: Global: Blood Preparation Market Forecast: Breakup by Antithrombotic and Anticoagulants Application (in Million US$), 2024-2032
  • Table 5: Global: Blood Preparation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Blood Preparation Market: Competitive Structure
  • Table 7: Global: Blood Preparation Market: Key Players
目次
Product Code: SR112024A4552

The global blood preparation market size reached US$ 44.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.

Blood donation is a lifesaving procedure wherein one unit of blood is taken from the donor. This blood consists of a mixture of cellular elements, colloids, and crystalloids, which need to be separated for being used in patients. As a result, the blood preparation method is widely adopted to separate one-unit whole blood into different components using refrigerated centrifuge equipment. These components generally include cryoprecipitate, platelet concentrate, fresh frozen plasma, and packed red blood cell (PRBC) concentrate. The blood preparation method also maximizes the utility of each blood component for a different applications.

Blood Preparation Market Trends:

Due to the surging cases of coronavirus disease (COVID-19) and the lack of effective treatment, several hospitals are relying on convalescent plasma as a promising treatment for patients with critical conditions. This represents one of the key factors positively influencing the need for blood preparation methods to separate plasma from healthy blood donations. Apart from this, the growing prevalence of chronic disorders, such as anemia, sickle cell disease, hemophilia, and cancer, is catalyzing the demand for blood transfusion. This, in confluence with the rising number of blood donors on account of awareness campaigns conducted by governmental and non-governmental organizations (NGOs) worldwide, is contributing to the market growth. In line with this, a significant rise in the number of surgical procedures is also bolstering the growth of the market. Moreover, several healthcare institutions are focusing on employing advanced digital technologies for the speedy separation of blood components. They are also utilizing radio frequency identification (RFID) technology for maintaining blood inventory records, which is anticipated to expand the application of blood preparation methods in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global blood preparation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, antithrombotic and anticoagulants type, and antithrombotic and anticoagulants application.

Breakup by Product:

Whole Blood

Red Cells

Granulocytes

Plasma

Platelets

Blood Components

Whole Blood Components

Packed Red Cells

Leukocyte Reduced Red Blood Cells

Frozen Plasma

Platelet Concentrate

Cryoprecipitate

Blood Derivatives

Breakup by Antithrombotic and Anticoagulants Type:

Platelet Aggregation Inhibitors

Glycoprotein Inhibitors

COX Inhibitors

ADP Antagonists

Others

Fibrinolytics

Tissue Plasminogen Activator (TPA)

Streptokinase

Urokinase

Anticoagulants

Heparins

Vitamin K Antagonists

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Breakup by Antithrombotic and Anticoagulants Application:

Thrombocytosis

Pulmonary Embolism

Renal Impairment

Angina Blood Vessel Complications

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, GlaxoSmithKline PLC, Johnson & Johnson Services Inc., LEO Pharma A/S, Pfizer Inc., Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.) and Sanofi S.A.

Key Questions Answered in This Report

  • 1. What was the size of the global blood preparation market in 2023?
  • 2. What is the expected growth rate of the global blood preparation market during 2024-2032?
  • 3. What are the key factors driving the global blood preparation market?
  • 4. What has been the impact of COVID-19 on the global blood preparation market?
  • 5. What is the breakup of the global blood preparation market based on the product?
  • 6. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants type?
  • 7. What is the breakup of the global blood preparation market based on the antithrombotic and anticoagulants application?
  • 8. What are the key regions in the global blood preparation market?
  • 9. Who are the key players/companies in the global blood preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Blood Preparation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Whole Blood
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Red Cells
      • 6.1.2.2 Granulocytes
      • 6.1.2.3 Plasma
      • 6.1.2.4 Platelets
    • 6.1.3 Market Forecast
  • 6.2 Blood Components
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Whole Blood Components
      • 6.2.2.2 Packed Red Cells
      • 6.2.2.3 Leukocyte Reduced Red Blood Cells
      • 6.2.2.4 Frozen Plasma
      • 6.2.2.5 Platelet Concentrate
      • 6.2.2.6 Cryoprecipitate
    • 6.2.3 Market Forecast
  • 6.3 Blood Derivatives
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Antithrombotic and Anticoagulants Type

  • 7.1 Platelet Aggregation Inhibitors
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Glycoprotein Inhibitors
      • 7.1.2.2 COX Inhibitors
      • 7.1.2.3 ADP Antagonists
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Fibrinolytics
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Tissue Plasminogen Activator (TPA)
      • 7.2.2.2 Streptokinase
      • 7.2.2.3 Urokinase
    • 7.2.3 Market Forecast
  • 7.3 Anticoagulants
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 Heparins
      • 7.3.2.2 Vitamin K Antagonists
      • 7.3.2.3 Direct Thrombin Inhibitors
      • 7.3.2.4 Direct Factor Xa Inhibitors
    • 7.3.3 Market Forecast

8 Market Breakup by Antithrombotic and Anticoagulants Application

  • 8.1 Thrombocytosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pulmonary Embolism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Renal Impairment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Angina Blood Vessel Complications
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Baxter International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Boehringer Ingelheim International GmbH
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bristol-Myers Squibb Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Daiichi Sankyo Company Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 GlaxoSmithKline PLC
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson Services Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 LEO Pharma A/S
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Portola Pharmaceuticals Inc. (Alexion Pharmaceuticals Inc.)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanofi S.A.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis